Amy Redding

Amy Redding is a seasoned marketing professional with extensive experience in the pharmaceutical sector, currently serving as Senior Director of Global Strategic Marketing at Merck Group since July 2019. In this role, Amy leads the brand development for evobrutinib and has previously directed global strategic marketing for multiple sclerosis (MS) initiatives. Amy has a robust background in marketing leadership roles within neurology and immunology, including managing UK and ROI marketing teams and spearheading peer-to-peer programs with key thought leaders. Prior to Merck Group, Amy held various positions at GSK from January 2012 to July 2019, focusing on customer experience, sales management, and brand strategy. Academic credentials include multiple programs from Harvard Business School and INSEAD, alongside a Bachelor of Science in Pharmacology and Toxicology and a Bachelor of Commerce in Marketing from the University of Otago.